Skip to content
SURVIVEiT Logo FINAL_RGB Color w R
  • Home
  • About
  • Resources
  • Newsroom
  • Contact Us
  • Navigation Tool
DONATE

Cancer & SURVIVEiT News

Category Filter:

Endometrial Cancer, Uterine Cancer

FDA approves combo KEYTRUDA + LENVIMA for some endometrial carcinoma patients

September 17, 2019

On September 17, 2019, the Food and Drug Administration granted accelerated approval to the combination of pembrolizumab (KEYTRUDA, Merck) plus lenvatinib (LENVIMA, Eisai) for the treatment of patients with advanced…

Categories

  • Bile Duct Cancer
  • Bladder Cancer
  • Blog
  • Bone Cancer
  • Brain Cancer
  • Breast Cancer
  • Cancer Diagnosis
  • Cancer Navigation tool
  • Cancer Survivor Q&A
  • Cancer Updates
  • Caregivers
  • Childhood & Young Adult Cancer
  • Colon Cancer
  • COVID + Cancer
  • Endometrial Cancer
  • Esophageal Cancer
  • Guest Blog
  • Head & Neck Cancer
  • Kidney & Renal Cancer
  • Leukemia
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Medical News
  • Melanoma
  • Myeloma
  • Navigating Now: Cancer Blog
  • Ovarian Cancer
  • Pancreatic
  • Prevention & Lifestyle News
  • Prostate Cancer
  • Sarcoma
  • Stomach Cancer
  • Stories of Survival
  • SURVIVEiT News
  • Testicular Cancer
  • Uncategorized
  • Uterine Cancer
SURVIVEiT Logo FINAL_RGB White w R
Mailing Address: PO Box 202187, Denver, CO 80220

PO Box 202187, Denver, CO 80220

email: info@surviveit.org

info@surviveit.org

terms of use

Privacy Policy

terms of use

Terms Of Use

Newsletter

© 2020 SURVIVEiT® is a registered 501(c)(3) nonprofit organization. EIN 46-3365665

Website generously created by 48in48

DONATE